Cheetio, Thank You!...A terrific example of what good/any PR can accomplish. Title of article attached... "PD1 drugs could end 'DECADES OF SILENCE' in bladder cancer therapy"... BUT WAIT?!?! - Keytruda is a Phase 1b trial with a sample size of 29 patients (over a short period). Excerpt from link below - A phase Ib trial of Keytruda revealed that as a monotherapy the drug achieved a 24% overall response rate in patients with PDL1-positive tumours, with three of the 29 patients in the small study achieved a complete response. At the time of analysis, patients had shown responses of between 16 and 40-plus weeks. - https://www.pmlive.com/pharma_news/pd-1_drugs_could_end_decades_of_silence_in_bladder_cancer_therapy_602658 - and link to Merck's press release - - https://www.businesswire.com/news/home/20140929005263/en/Merck-Announces-Presentation-Early-Data-Investigational-KEYTRUDA%C2%AE#.VMqNoM50ypo